e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
Pulmonary hypertension: pathophysiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Platelet-activating factor-acetylhydrolase (PAF-AH) activity in pulmonary arterial hypertension (PAH)
R. Quarck, E. Ninio, H. Durand, W. Daenen, D. Marion (Leuven, Belgium; Paris, France)
Source:
Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Session:
Pulmonary hypertension: pathophysiology
Session type:
Oral Presentation
Number:
4429
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Quarck, E. Ninio, H. Durand, W. Daenen, D. Marion (Leuven, Belgium; Paris, France). Platelet-activating factor-acetylhydrolase (PAF-AH) activity in pulmonary arterial hypertension (PAH). Eur Respir J 2005; 26: Suppl. 49, 4429
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Could platelet-activating factor acetylhydrolase (PAF-AH) predict adverse event in pulmonary hypertension?
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
C-reactive protein and platelet-activating factor-acetylhydrolase activity: new predictors of outcome in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Arterial concentration of macrophage migration inhibitory factor (MIF) increases with exercise in patients with pulmonary hypertension (PH)
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Platelets and pulmonary arterial hypertension (PAH)
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Effects of endothelin receptor antagonist (ERA) bosentan on myocardial glucose metabolism in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002
Arterial hypertension (AH) and endothelial function (EF) in patients with COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Atrial natriuretic peptide plasma concentration (ANP) and pulmonary hemodynamics (HEMO) after acute nitric oxide inhalation (NO) in patients with connective tissue disease and pulmonary artery hypertension (CTDPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 561s
Year: 2005
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH).
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
High-altitude pulmonary hypertension
Source: Eur Respir Rev 2009; 18: 13-17
Year: 2009
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 881-891
Year: 2008
Pharmacologic characterization of GB002, a novel inhaled PDGFR kinase inhibitor in development for pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Measurement of gas transfer components using nitric oxide in post pulmonary endartectomy (PEA) chronic thromboembolic hypertension (CTEPH) patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
6MWD in patients with pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2003; 22: Suppl. 45, 464s
Year: 2003
Epoprostenol (EPT) for acute reactivity testing (AVT) in pulmonary artery hypertension (PAH)
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004
Monocyte chemotactic protein-1 (MCP-1) synthesis and function in pulmonary artery smooth muscle cells (PA-SMCs) from patients with idiopathic pulmonary hypertension (IPH)
Source: Eur Respir J 2004; 24: Suppl. 48, 436s
Year: 2004
Pathways in pulmonary arterial hypertension: the future is here
Source: Eur Respir Rev 2012 21: 321-327
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept